01 1Roquette Freres SA
01 1ADRABETADEX
01 1France
NDC Package Code : 50516-003
Start Marketing Date : 2020-08-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Adrabetadex manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Adrabetadex, including repackagers and relabelers. The FDA regulates Adrabetadex manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Adrabetadex API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Adrabetadex supplier is an individual or a company that provides Adrabetadex active pharmaceutical ingredient (API) or Adrabetadex finished formulations upon request. The Adrabetadex suppliers may include Adrabetadex API manufacturers, exporters, distributors and traders.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Adrabetadex as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Adrabetadex API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Adrabetadex as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Adrabetadex and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Adrabetadex NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Adrabetadex suppliers with NDC on PharmaCompass.
LOOKING FOR A SUPPLIER?
